In a market dominated by giants like Veeva and Salesforce, QPharma isn't trying to be everything to everyone. Instead, it has built a $38.4M fortress around the specific, high-stakes pain points of life sciences compliance.

"The 51% direct traffic rate is telling: this isn't a company chasing cold leads; it's a vendor with sticky, returning enterprise clients."

The traffic distribution is polarized: 51.1% from one undefined region and 48.9% from another. This lack of geographic diversity could be a risk, but it also suggests a concentrated, likely North American, enterprise customer base that drives high-value contracts rather than high-volume clicks.

• Niche Dominance: They aren't fighting Salesforce for the SMB market; they are protecting pharma giants from compliance failures.
• High-Touch Model: With 191 employees serving $38.4M in revenue (~$200k revenue per employee), the model is consultancy-heavy, not just SaaS.
• Legacy Stack, Modern Problems: Using jQuery and Bootstrap suggests a focus on stability and enterprise compatibility over trendy frontend frameworks.